NCT04083859Completed
Digital Outreach Intervention for Lung Cancer Screening
A Pragmatic Randomized-Controlled Trial of a Digital Outreach Intervention for Lung Cancer Screening: mPATH-Lung (Mobile Patient Technology for Health-Lung)
Source: ClinicalTrials.gov · Last updated 25 Jun 2025
Brief summary (registry, in English)
mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic randomized-controlled trial conducted with primary care patients in two large health networks, 2) Elucidate the drivers of patients' screening decisions and screening behavior; and 3) Explore implementation outcomes that will impact the sustainability and dissemination of mPATH-Lung using program data, surveys, and interviews. This project will determine how mPATH-Lung affects patients' screening decisions and their completion of screening.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 26998 (actual)
- First submitted
- 30 Aug 2019
- Start date
- 1 Jan 2022
- Primary completion date
- 30 Sept 2023
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Lung cancer
- NCT number
- NCT04083859
What you commit to
- Study type: Interventional
- Participants enrolled: 26998
- From 1 Jan 2022 to the primary completion date, 30 Sept 2023
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Those for whom lung cancer screening would be inappropriate:
- Prior history of lung cancer
- Chest CT within the last 12 months
- Those with medical conditions predicting shorter life expectancy
- Patients whose home address is not within the state of North Carolina. (Due to telehealth guidelines)
Other
- Patients flagged as needing a language interpreter in the electronic health record (electronic messages and intervention is delivered in English only).
Who the study is looking for
- Meet the Medicare criteria for lung cancer screening, as updated in February 2022:
- Age 50 - 77 years
- Smoked at least 20 pack years
- Current smoker or quit smoking within the past 15 years
- Be scheduled to see a primary care provider within the health network in the next 3-4 weeks
- Have a patient portal account or cellphone number listed in the electronic health record
Age in the registry: 50 years to 77 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of North Carolina, Chapel Hill Coordinator of this site? Confirm its status | Chapel Hill | United States | Unknown status |
| Wake Forest Baptist Medical Center Coordinator of this site? Confirm its status | Winston-Salem | United States | Unknown status |
Related publications
- Using Digital Outreach to Identify Individuals Eligible for Lung Cancer Screening: A Secondary Analysis of a Randomized Trial.J Gen Intern Med · 2026 · PMID 42870174
This page is information, not medical advice. Discuss any trial with your doctor.